Teresa Mattarelli
Corporate Officer/Principal bei Perspectum Group Ltd.
Profil
Teresa Mattarelli is currently the Chief Commercial Officer at Perspectum Group Ltd.
Prior to this, she worked at Medtronic Plc as the Global Vice President & General Manager from 2019 to 2020.
She completed her undergraduate degree and MBA from McGill University.
Aktive Positionen von Teresa Mattarelli
| Unternehmen | Position | Beginn |
|---|---|---|
Perspectum Group Ltd.
 Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 01.02.2021 |
Ehemalige bekannte Positionen von Teresa Mattarelli
| Unternehmen | Position | Ende |
|---|---|---|
| MEDTRONIC PLC | Corporate Officer/Principal | 01.11.2020 |
Ausbildung von Teresa Mattarelli
| McGill University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MEDTRONIC PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Perspectum Group Ltd.
Perspectum Group Ltd. Packaged SoftwareTechnology Services Perspectum Group Plc engages in the sale of diagnostic products via a software-as-a-medical device platform. Its products combine expertise in image formation, magnetic resonance image analysis and artificial intelligence to support healthcare provider diagnosis, treatment decision-making, and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer, and determine whether the patient is responding to therapy. Its products include Liver MultiScan, MRCP+, Hepatica, and CoverScan MD. The company was founded by Matthew Robson on June 10, 2021 and is headquartered in Oxford, the United Kingdom. | Technology Services |
